Security Snapshot

FIRST TR EXCHANGE TRADED FD - HLTH CARE ALPH (FXH) Institutional Ownership

CUSIP: 33734X143

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

235

Shares (Excl. Options)

4,433,985

Price

$113.82

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Type / Class
Equity / HLTH CARE ALPH
Symbol
FXH
Price per share
$109.77
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
4,433,985
Total reported value
$504,717,975
% of total 13F portfolios
0%
Share change
+36,968
Value change
+$4,519,271
Number of holders
235
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • FXH - FIRST TR EXCHANGE TRADED FD - HLTH CARE ALPH is tracked under CUSIP 33734X143.
  • 235 institutions reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 235 to 74 between Q4 2025 and Q1 2026.
  • Reported value moved from $504,717,975 to $65,742,685.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 235 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 33734X143?
CUSIP 33734X143 identifies FXH - FIRST TR EXCHANGE TRADED FD - HLTH CARE ALPH in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 235 institutional investors reported holding 4,433,985 shares of FIRST TR EXCHANGE TRADED FD - HLTH CARE ALPH (FXH).

Institutional Holders of FIRST TR EXCHANGE TRADED FD - HLTH CARE ALPH (FXH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 598,588 $65,742,685 -$1,927,115 $109.77 74
2025 Q4 4,433,985 $504,717,975 +$4,519,271 $113.82 235
2025 Q3 4,265,389 $467,668,921 -$14,872,061 $109.67 218
2025 Q2 4,418,009 $458,033,775 -$34,708,623 $103.68 221
2025 Q1 4,740,278 $491,070,787 -$53,644,576 $103.60 243
2024 Q4 5,282,277 $550,243,649 -$80,897,372 $104.13 249
2024 Q3 6,025,631 $673,731,100 -$42,196,903 $111.86 252
2024 Q2 6,439,682 $673,244,499 -$25,807,560 $104.52 251
2024 Q1 6,697,431 $733,438,889 -$14,618,416 $109.59 262
2023 Q4 6,868,196 $711,655,529 -$74,522,555 $103.55 261
2023 Q3 7,570,418 $735,947,398 -$86,600,423 $97.16 247
2023 Q2 8,420,349 $911,801,589 +$6,221,962 $108.31 253
2023 Q1 8,376,232 $900,654,392 +$10,961,213 $107.53 251
2022 Q4 8,261,105 $898,383,751 +$29,219,469 $108.73 255
2022 Q3 7,957,770 $773,873,117 +$79,118,696 $97.20 244
2022 Q2 7,118,660 $734,283,516 +$94,642,447 $103.12 236
2022 Q1 6,267,955 $718,274,861 -$17,197,541 $114.66 228
2021 Q4 6,359,232 $788,873,150 -$38,121,079 $124.16 235
2021 Q3 6,598,815 $785,605,798 +$8,826,477 $119.04 211
2021 Q2 6,446,490 $755,140,245 +$21,910,514 $117.12 213
2021 Q1 6,268,728 $680,465,439 -$79,824,641 $108.61 205
2020 Q4 6,974,921 $751,996,371 -$19,932,331 $107.78 219
2020 Q3 7,032,403 $666,371,011 -$58,900,480 $94.74 197
2020 Q2 7,636,466 $688,975,892 -$403,974,775 $90.20 199
2020 Q1 12,910,151 $955,285,881 +$425,471,645 $73.97 185
2019 Q4 7,206,291 $606,957,732 -$8,285,216 $84.20 198
2019 Q3 7,224,403 $534,759,065 -$63,446,922 $74.02 169
2019 Q2 8,061,209 $624,008,313 -$867,158,600 $77.45 175
2019 Q1 19,538,787 $1,492,637,682 -$55,588,172 $76.41 192
2018 Q4 20,532,560 $1,416,752,299 +$867,429,791 $68.87 186
2018 Q3 7,651,875 $648,544,990 +$106,954,082 $84.88 157
2018 Q2 6,398,730 $474,834,576 +$24,272,386 $74.22 147
2018 Q1 6,078,030 $421,966,214 -$52,152,473 $69.40 147
2017 Q4 6,834,591 $477,128,476 -$64,535,551 $69.80 143
2017 Q3 7,664,540 $516,735,197 -$2,401,773 $67.42 131
2017 Q2 7,709,430 $515,183,372 +$36,686,399 $66.86 129
2017 Q1 7,170,701 $447,533,440 -$18,177 $62.42 129
2016 Q4 7,178,061 $412,158,215 -$98,910,855 $57.30 114
2016 Q3 8,815,852 $535,937,881 +$4,987,732 $60.85 132
2016 Q2 8,846,509 $521,941,884 -$176,565,330 $58.94 127
2016 Q1 11,783,675 $657,761,787 -$1,723,366,706 $55.74 125
2015 Q4 41,352,955 $2,498,157,179 +$50,137,926 $60.45 148
2015 Q3 40,197,950 $2,342,995,749 +$79,737,673 $58.20 143
2015 Q2 41,131,544 $2,831,114,465 +$452,151,078 $68.85 145
2015 Q1 34,525,638 $2,312,577,350 +$468,880,805 $67.02 141
2014 Q4 27,381,975 $1,651,019,967 -$86,458,532 $60.29 127
2014 Q3 28,838,353 $1,608,472,914 +$246,794,325 $55.79 115
2014 Q2 24,582,145 $1,300,637,372 -$27,069,835 $53.27 103
2014 Q1 25,017,337 $1,273,847,340 +$274,754,026 $50.94 96
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .